Network medicine is a network-based approach to understanding human disease, emphasizing the complex interactions within cellular networks. Diseases are not solely caused by mutations in a single gene but result from perturbations in complex intracellular networks. Advances in network medicine help identify disease modules, pathways, and the molecular relationships between distinct phenotypes. This approach is crucial for discovering disease genes, understanding mutations from genome-wide association studies, and identifying drug targets and biomarkers for complex diseases. The human interactome, comprising interactions between proteins, metabolites, and RNA, is highly interconnected. Disease genes often reside in hubs of the interactome, which are highly connected proteins. Essential genes, which are vital for cellular function, are more likely to be hubs. However, not all disease genes are hubs; many are located at the periphery of the interactome. Disease modules, groups of proteins that contribute to a specific cellular function, are central to understanding disease mechanisms. These modules can overlap with topological and functional modules, and their identification helps in understanding disease progression and developing targeted therapies. Network-based methods, such as co-expression networks and genetic networks, help identify disease modules. These methods have been applied to various diseases, including cancer and infectious diseases. Bioinformatics approaches and experimental mapping of disease modules have led to the identification of key disease-related genes and pathways. Predictive models, including diffusion-based and modularity-based methods, help identify potential disease genes by analyzing network topology and functional relationships. The concept of the diseasome, a network of diseases linked by shared genes, metabolic pathways, or phenotypic features, provides insights into disease comorbidity and progression. Shared gene, metabolic pathway, and microRNA hypotheses have been used to construct disease networks, revealing how diseases are interconnected. Phenotypic disease networks, based on observed comorbidities, further highlight the relationships between diseases. Network medicine also has applications in drug discovery and development. Network pharmacology emphasizes the interconnectedness of drug targets and cellular components, leading to the identification of multi-target drug combinations. This approach is essential for developing effective treatments for complex diseases. Disease classification based on network principles offers a more comprehensive understanding of disease mechanisms, enabling personalized therapies. In conclusion, network medicine provides a framework for understanding the complex interactions within cellular networks that underlie human diseases. By integrating network-based approaches, researchers can better identify disease mechanisms, develop targeted therapies, and improve disease classification and treatment strategies.Network medicine is a network-based approach to understanding human disease, emphasizing the complex interactions within cellular networks. Diseases are not solely caused by mutations in a single gene but result from perturbations in complex intracellular networks. Advances in network medicine help identify disease modules, pathways, and the molecular relationships between distinct phenotypes. This approach is crucial for discovering disease genes, understanding mutations from genome-wide association studies, and identifying drug targets and biomarkers for complex diseases. The human interactome, comprising interactions between proteins, metabolites, and RNA, is highly interconnected. Disease genes often reside in hubs of the interactome, which are highly connected proteins. Essential genes, which are vital for cellular function, are more likely to be hubs. However, not all disease genes are hubs; many are located at the periphery of the interactome. Disease modules, groups of proteins that contribute to a specific cellular function, are central to understanding disease mechanisms. These modules can overlap with topological and functional modules, and their identification helps in understanding disease progression and developing targeted therapies. Network-based methods, such as co-expression networks and genetic networks, help identify disease modules. These methods have been applied to various diseases, including cancer and infectious diseases. Bioinformatics approaches and experimental mapping of disease modules have led to the identification of key disease-related genes and pathways. Predictive models, including diffusion-based and modularity-based methods, help identify potential disease genes by analyzing network topology and functional relationships. The concept of the diseasome, a network of diseases linked by shared genes, metabolic pathways, or phenotypic features, provides insights into disease comorbidity and progression. Shared gene, metabolic pathway, and microRNA hypotheses have been used to construct disease networks, revealing how diseases are interconnected. Phenotypic disease networks, based on observed comorbidities, further highlight the relationships between diseases. Network medicine also has applications in drug discovery and development. Network pharmacology emphasizes the interconnectedness of drug targets and cellular components, leading to the identification of multi-target drug combinations. This approach is essential for developing effective treatments for complex diseases. Disease classification based on network principles offers a more comprehensive understanding of disease mechanisms, enabling personalized therapies. In conclusion, network medicine provides a framework for understanding the complex interactions within cellular networks that underlie human diseases. By integrating network-based approaches, researchers can better identify disease mechanisms, develop targeted therapies, and improve disease classification and treatment strategies.